&nbsp;

plansPrintBtnIconPurple2.png

Nov 2020

Document

plansPrintBtnIconPurple3.png

Nov 2020

Regimen

ALPEFLVS

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

fulvestrant

Drugs Used:

fulvestrant,

alpelisib (Unfunded)

Quick Link(s):

Regimen Monograph

Jul 2023

Regimen

AVEL(MNT)

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Palliative

Funding:

New Drug Funding Program

Avelumab - Maintenance Treatment for Unresectable Locally Advanced or Metastatic Urothelial Carcinoma

Drugs Used:

avelumab

Quick Link(s):

Regimen Monograph

Jan 2025

Regimen

PEMB

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - First Line Treatment of MSI-H/dMMR Metastatic Colorectal Cancer

Drugs Used:

pembrolizumab

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

PEGA(DESEN)

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL),

Lymphoma - T-cell

Intent: Curative

Drugs Used:

pegaspargase

Quick Link(s):

Regimen Monograph

Feb 2022

Document

PCC_4244_ICCU-ColonScreeningFactSheet-FN-FR.pdf

Mar 2021

Document

PCC_4244_ICCU-ColonScreeningFactSheet-Inuit-FR.pdf

Mar 2021

Document

PCC_4244_ICCU-ColonScreeningFactSheet-Metis-FR.pdf

Mar 2021

Document

PCC_4245_BreastScreening_FactSheet_FN_FR_AODA.pdf

Mar 2021

Document

PCC_4245_BreastScreening_FactSheet_Innuit_FR_AODA.pdf

Mar 2021

Document